2nd Quarter - Report

SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING for SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Energy/Nuclear ENG

Patient dosing issues with NRC's ACMUI.

LobbyistCovered position, as disclosed
WAYNE ALAN POWELL —

Contacted: SENATE; Nuclear Regulatory Commission (NRC); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Energy, Dept of; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Medicare coverage and reimbursement.

LobbyistCovered position, as disclosed
WAYNE ALAN POWELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Nuclear Regulatory Commission (NRC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Energy, Dept of; Office of Science & Technology Policy (OSTP)

Medicare/Medicaid MMM

Medicare coverage and reimbursement.

LobbyistCovered position, as disclosed
WAYNE ALAN POWELL —

Contacted: Nuclear Regulatory Commission (NRC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Office of Science & Technology Policy (OSTP); Energy, Dept of; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Compounding of radiopharmaceuticals.

LobbyistCovered position, as disclosed
WAYNE ALAN POWELL —

Contacted: HOUSE OF REPRESENTATIVES; Nuclear Regulatory Commission (NRC); Office of Science & Technology Policy (OSTP); Energy, Dept of; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.